en

PRODUCT DETAIL

Amvuttra 25 mg injekčný roztok v naplnenej injekčnej striekačke

Code 2040E
MA number EU/1/22/1681/001
Product Form: sol inj 1x0,5 ml/25 mg (striek.inj.napl.skl. + ihla)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 87 - VARIA I
ATC:
N NERVOUS SYSTEM
N07 OTHER NERVOUS SYSTEM DRUGS
N07X OTHER NERVOUS SYSTEM DRUGS
N07XX Other nervous system drugs
N07XX18 Vutrisiran
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 15.09.2022
Validity: 15.09.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.09.2022
eu-flag.png sk-flag.png